Approval · Notice of Compliance 9098 · 2007
FOSRENOL: Notice of Compliance 9098
Issued October 16, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9098
- Date
- October 16, 2007
- Company
- Shire Canada IncLaval, QC, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Phosphate binder
Products in this notice
Medicinal ingredients
- LANTHANUM CARBONATE HYDRATE 250 MG per TAB
- LANTHANUM CARBONATE HYDRATE 500 MG per TAB
- LANTHANUM CARBONATE HYDRATE 750 MG per TAB
- LANTHANUM CARBONATE HYDRATE 1,000 MG per TAB